Sebastiano Bucello

A pilot trial of low-dose naltrexone in primary progressive multiple sclerosis

M. Gironi, Filippo Martinelli Boneschi, Paola Sacerdote et al. · Multiple Sclerosis Journal · 2008 · 94 citations

Efficacy and tolerability of natalizumab in relapsing–remitting multiple sclerosis patients: a post-marketing observational study

Francesca Sangalli, Lucia Moiola, Sebastiano Bucello et al. · Neurological Sciences · 2010 · 59 citations

Multiple Sclerosis Patients, Novel Therapy, Systemic Scleroderma +7

SARS-CoV-2 serology after COVID-19 in multiple sclerosis: An international cohort study

Maria Pia Sormani, Irene Schiavetti, Doriana Landi et al. · Multiple Sclerosis Journal · 2021 · 52 citations · Full text

Exposure to natalizumab throughout pregnancy: effectiveness and safety in an Italian cohort of women with multiple sclerosis

Doriana Landi, Francesca Bovis, Alfonso Grimaldi et al. · Journal of Neurology Neurosurgery & Psychiatry · 2022 · 27 citations

Disease-modifying therapies in managing disability worsening in paediatric-onset multiple sclerosis: a longitudinal analysis of global and national registries

Sifat Sharmin, Izanne Roos, Charles B. Malpas et al. · The Lancet Child & Adolescent Health · 2024 · 26 citations · Full text

Disease-modifying Therapies, Neurological Disorder, Disability +11